Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -8.80%1.13M | 372.10%5.04M | -425.78%-2.29M | -71.69%2.01M | 1.92M | 1.24M | -1.85M | 702K | -7.73%7.09M | -52.01%7.69M |
| Net profit before non-cash adjustment | 44.42%569K | 97.39%-69K | -67.88%1.05M | -73.50%3.26M | --2.25M | --394K | ---2.64M | --3.27M | 9.92%12.32M | -19.58%11.2M |
| Total adjustment of non-cash items | 26.48%1.61M | -31.75%963K | 15.25%1.18M | 64.13%5.5M | --1.8M | --1.27M | --1.41M | --1.02M | 17.58%3.35M | -27.17%2.85M |
| -Depreciation and amortization | -6.97%947K | 33.84%969K | 83.76%928K | 45.66%3.19M | --938.71K | --1.02M | --724K | --505K | -12.24%2.19M | -0.16%2.49M |
| -Reversal of impairment losses recognized in profit and loss | 404.96%611K | --0 | ---8K | 2,447.94%937.7K | --661.7K | --121K | --155K | --0 | -110.19%-39.94K | -103.17%-19K |
| -Disposal profit | --0 | ---112K | --0 | 73.25%-30K | --0 | ---30K | --0 | --0 | -103.93%-112.16K | -117.46%-55K |
| -Net exchange gains and losses | ---34K | ---99K | --61K | 328.01%52.17K | --52.17K | --0 | --0 | --0 | 72.43%-22.88K | -260.87%-83K |
| -Other non-cash items | 57.50%252K | -61.47%205K | -61.78%198K | 1.11%1.35M | --142.59K | --160K | --532K | --518K | 160.27%1.34M | -2.10%514K |
| Changes in working capital | -145.88%-1.05M | 769.03%4.15M | -25.79%-4.52M | 21.21%-6.75M | ---2.12M | ---425K | ---620K | ---3.59M | -34.68%-8.57M | -249.15%-6.37M |
| -Change in receivables | 167.62%2.43M | -49.17%1.23M | 274.80%1.07M | 56.42%-2.86M | ---1.07M | ---3.59M | --2.42M | ---611K | 11.99%-6.55M | -229.77%-7.45M |
| -Change in inventory | -305.10%-3.34M | -140.50%-179K | 37.17%310K | 144.86%613.1K | ---1.68M | --1.63M | --442K | --226K | -194.06%-1.37M | 132.19%1.45M |
| -Change in payables | -242.25%-1.53M | 209.45%4.07M | -120.14%-5.52M | -448.75%-4.97M | --177.5K | --1.08M | ---3.72M | ---2.51M | -539.52%-905.42K | 116.60%206K |
| -Changes in other current assets | ---- | -514.53%-970K | 46.28%-375K | 80.98%457.2K | --459.2K | --462K | --234K | ---698K | 143.63%252.62K | 67.92%-579K |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | 0 | 0 | 0 | 86.27%-28.78K | 220 | 0 | -12K | -17K | -255.35%-209.66K | 72.04%-59K |
| Interest received (cash flow from operating activities) | 0 | 19 | 0 | |||||||
| Tax refund paid | 41.49%-557K | 60.22%-389K | 68.93%-284K | 0.49%-3.03M | -190.4K | -952K | -978K | -914K | -8.79%-3.05M | 19.71%-2.8M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 100.00%572K | 263.67%4.65M | -1,022.71%-2.57M | -127.51%-1.05M | --1.73M | --286K | ---2.84M | ---229K | -20.55%3.83M | -60.82%4.83M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 65.01%-359K | 73.25%-425K | 63.84%-260K | -240.27%-4.39M | ---1.06M | ---1.03M | ---1.59M | ---719K | 75.40%-1.29M | -229.11%-5.25M |
| Net intangibles purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---200K |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---75K |
| Net investment product transactions | --0 | ---- | ---- | ---- | ---- | ---5.51M | ---- | ---- | --0 | --0 |
| Interest received (cash flow from investment activities) | -7.69%12K | 233.33%20K | --13K | --54.1K | --35.1K | --13K | --6K | --0 | --0 | ---- |
| Net changes in other investments | ---- | ---- | ---- | 307.30%298.51K | ---4.49K | --1.9M | ---- | ---- | -200.70%-144K | --143K |
| Investing cash flow | 74.73%-1.57M | 87.28%-405K | 65.65%-247K | -181.53%-4.04M | --6.09M | ---6.22M | ---3.18M | ---719K | 73.33%-1.43M | -243.86%-5.38M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | -102.25%-111K | 94.13%-1.6M | -261.80%-1.49M | -6,890.93%-22.62M | --117.23K | --4.94M | ---27.26M | ---411K | -115.91%-323.57K | 456.84%2.03M |
| Net common stock issuance | --0 | ---- | ---- | --37.4M | --1.34M | --0 | ---- | ---- | --0 | --225K |
| Increase or decrease of lease financing | 15.58%-65K | -9.46%-81K | 9.21%-69K | -39.92%-303.97K | ---76.97K | ---77K | ---74K | ---76K | 55.39%-217.24K | 31.31%-487K |
| Cash dividends paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 46.00%-351K |
| Interest paid (cash flow from financing activities) | -56.65%-271K | 55.70%-233K | 56.49%-218K | -21.38%-1.38M | ---180.39K | ---173K | ---526K | ---501K | -146.68%-1.14M | -46.82%-461K |
| Net other fund-raising expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --431K |
| Financing cash flow | -83.40%778K | -123.37%-1.92M | -79.55%-1.77M | 880.38%13.09M | --1.2M | --4.69M | --8.19M | ---988K | -220.63%-1.68M | 162.02%1.39M |
| Net cash flow | ||||||||||
| Beginning cash position | 91.75%11.52M | 139.17%9.19M | 138.51%13.78M | 14.28%5.78M | --4.76M | --6.01M | --3.84M | --5.78M | 19.90%5.06M | 198.21%4.22M |
| Current changes in cash | 82.23%-222K | 7.66%2.33M | -137.19%-4.59M | 1,008.06%8M | --9.02M | ---1.25M | --2.17M | ---1.94M | -13.92%722.18K | -90.14%839K |
| End cash Position | 137.39%11.3M | 91.75%11.52M | 139.17%9.19M | 138.48%13.78M | --13.78M | --4.76M | --6.01M | --3.84M | 14.29%5.78M | 19.90%5.06M |
| Free cash flow | 127.66%213K | 192.87%4.12M | -198.63%-2.83M | -327.98%-5.48M | --674.7K | ---770K | ---4.43M | ---948K | 402.86%2.4M | -107.42%-793K |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.